S&P Biotech SPDR (XBI)

$67.40 2.74 (3.91%)

20:00 EDT XBI Stock Quote Delayed 30 Minutes

3 Market ETF Stocks to Buy This Week on Fed Jitters

By Nicolas Chahine, InvestorPlace Contributor Mar 14, 2022

The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.

3 Biotech Stocks to Buy That Are Under Severe Pressure

3 Stocks to Buy for the Second Half of 2021

3 Top Stock Trades for the Week

Volume:

Previous Close -

Market Cap 55.03M

PE Ratio -

EPS -

Volume (Avg. Vol.) 12.69M

Day's Range $66.94 - $69.47

52-Week Range $61.78 - $141.50

Dividend & Yield N/A (N/A)

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

From InvestorPlace
From the Web

7 Best Equal-Weight ETFs To Buy In June

By Tezcan Gecgil, InvestorPlace Contributor Jun 4, 2021

Financial planners highlight the benefits of ETFs track an equal-weighted index. Here are seven of the leading ETFs to consider in June.

7 Best Tech Index Funds for the Long-Haul Despite the Current Selloff

By Tezcan Gecgil, InvestorPlace Contributor May 24, 2021

The tech sector has been under pressure, but these seven index funds offer exposure to a range of tech shares and could become the building blocks of a successful growth portfolio.

3 Biotech Stocks to Buy As Things Heat Up for the Sector

By Tyler Craig, Tales of a Technician Feb 18, 2021

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.

The Cusp of an Amazing Technological Revolution

By Louis Navellier, Editor, Growth Investor Dec 15, 2020

We’re again at the cusp of an amazing technological revolution that will carry the stock market to incredible new highs. Make sure to position yourself to take advantage of this huge profit potential.

7 Index Funds To Buy For Diversified Growth in 2021

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Dec 7, 2020

Index funds offer investors the opportunity for diversified growth. With the S&P 500 and Dow Jones up so much in 2020, here are 7 others.

4 Biotech Stocks to Buy for Big Gains in 2020

By Tezcan Gecgil, InvestorPlace Contributor Sep 18, 2020

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 17, 2020

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

By Todd Shriber, InvestorPlace Contributor Aug 4, 2020

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

3 Healthcare Stocks to Buy This Year

By Nicolas Chahine, InvestorPlace Contributor Feb 24, 2020

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

3 Top Drug Stocks to Own In 2020

By Ian Cooper Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

4 Top Stock Trades for Friday: MU, Biotech, Bitcoin

By Bret Kenwell, InvestorPlace Contributor Sep 26, 2019

Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.

Hexo Stock Is Down — But Not Out

By Nicolas Chahine, InvestorPlace Contributor Sep 4, 2019

HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.

7 Biotech ETFs That Should Remain Healthy

By Todd Shriber, InvestorPlace Contributor Aug 5, 2019

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

7 of the Best SPDR ETFs — Besides SPY and GLD

By Todd Shriber, InvestorPlace Contributor Jul 3, 2019

SPDR ETFs span an array of asset classes, including stocks, bond, commodities and real estate, among others. Here are 7 of the best ETFs to buy from SPDR.

Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle

By Bret Kenwell, InvestorPlace Contributor Jun 27, 2019

Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.

IBB is up Over 5%, But the Market May Retest its Lows

By Ken Trester Jan 7, 2019

This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

7 Biotech ETFs to Consider for 2019

By Todd Shriber, InvestorPlace Contributor Nov 20, 2018

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

10 Best ETFs for 2018: Still a Close Race at the Head of the Pack

By Jessica Loder, InvestorPlace Assistant Editor Oct 10, 2018

As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.

10 Best ETFs for 2018: Biotechs Top the Charts at the Midpoint

By Jessica Loder, InvestorPlace Assistant Editor Jul 11, 2018

As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.

S&P Biotech SPDR (XBI)

3 Market ETF Stocks to Buy This Week on Fed Jitters

3 Biotech Stocks to Buy That Are Under Severe Pressure

3 Stocks to Buy for the Second Half of 2021

3 Top Stock Trades for the Week

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

S&P Biotech SPDR (XBI)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

Subscriber Sign in